Brokers Issue Forecasts for PVLA FY2024 Earnings

Palvella Therapeutics (NASDAQ:PVLA) – Analysts at Cantor Fitzgerald issued their FY2024 earnings per share estimates for shares of Palvella Therapeutics in a note issued to investors on Wednesday, December 18th. Cantor Fitzgerald analyst J. Schimmer forecasts that the company will post earnings of ($3.02) per share for the year. Cantor Fitzgerald has a “Overweight” rating on the stock.

Palvella Therapeutics Stock Performance

PVLA stock opened at $12.00 on Friday. Palvella Therapeutics has a 52-week low of $6.20 and a 52-week high of $22.32.

Insiders Place Their Bets

In related news, Director George M. Jenkins purchased 4,000 shares of the firm’s stock in a transaction on Wednesday, December 18th. The shares were bought at an average price of $12.93 per share, for a total transaction of $51,720.00. Following the acquisition, the director now directly owns 180,671 shares in the company, valued at $2,336,076.03. This trade represents a 2.26 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this link.